U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 25

1.
Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
Yu-zhe Cao, Jia-yu Pan, Guang-lei Zheng, Chao An, Meng-Xuan Zuo
Cancer Immunol Immunother. 2025 Jan; 74(1): 24. Published online 2024 Nov 14. doi: 10.1007/s00262-024-03872-6
PMCID:
PMC11564491
ArticlePDF–1.1M
2.
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Sho Matoya, Tomokatsu Miyaki, Yoshihide Kimura, Atsunori Kusakabe, Satoshi Narahara, Takayuki Tokunaga, Katsuya Nagaoka, Keita Kuroyanagi, Hayato Kawamura, Kayoko Kuno, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Yasuhito Tanaka
Cancer Med. 2024 Jan; 13(1): e6876. Published online 2023 Dec 22. doi: 10.1002/cam4.6876
PMCID:
PMC10807580
ArticlePDF–667K
3.
Combination treatment of pembrolizumab with DC-CIK cell therapy for advanced hepatocellular carcinoma: A case report
Shao M. Huang, Long-Bin Jeng, Woei-Cherng Shyu, Hung-Yao Chen
Biomedicine (Taipei) 2023; 13(3): 57–62. Published online 2023 Sep 1. doi: 10.37796/2211-8039.1414
PMCID:
PMC10627209
ArticlePDF–691K
4.
Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinoma
Juan Wu, Jia Zeng, Huiwen Wang, Zhuoni Huo, Xunbo Hou, Dongfeng He
Front Oncol. 2023; 13: 1244341. Published online 2023 Oct 17. doi: 10.3389/fonc.2023.1244341
PMCID:
PMC10616839
ArticlePDF–3.2M
5.
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma
Yusuke Kawamura, Norio Akuta, Junichi Shindoh, Masaru Matsumura, Satoshi Okubo, Licht Tominaga, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Takuyo Kozuka, Hiromitsu Kumada
Cancers (Basel) 2023 Aug; 15(15): 3789. Published online 2023 Jul 26. doi: 10.3390/cancers15153789
PMCID:
PMC10417036
ArticlePDF–7.8M
6.
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
Sujin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
J Liver Cancer. 2023 Mar; 23(1): 177–188. Published online 2023 Mar 23. doi: 10.17998/jlc.2023.03.04
PMCID:
PMC10202243
ArticlePDF–1.6M
7.
Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy
Beibei Xu, Dong Lu, Kaicai Liu, Weifu Lv, Jingkun Xiao, Xingming Zhang, Zhengfeng Zhang, Jie Chai, Lijun Wang
Drug Des Devel Ther. 2023; 17: 507–518. Published online 2023 Feb 16. doi: 10.2147/DDDT.S400533
PMCID:
PMC9940492
ArticlePDF–2.9M
8.
Prognostic Value of a CT Radiomics-Based Nomogram for the Overall Survival of Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
Lihong Wang, Danfang Yan, Liang Shen, Yalin Xie, Senxiang Yan
J Oncol. 2023; 2023: 1554599. Published online 2023 Jan 3. doi: 10.1155/2023/1554599
PMCID:
PMC9831699
ArticlePDF–973K
9.
Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study
Wei-Li Xia, Xiao-Hui Zhao, Yuan- Guo, Guang-Shao Cao, Gang Wu, Wei-Jun Fan, Quan-Jun Yao, Shi-Jun Xu, Chen-Yang Guo, Hong-Tao Hu, Hai-Liang Li
Front Oncol. 2022; 12: 961394. Published online 2022 Sep 30. doi: 10.3389/fonc.2022.961394
PMCID:
PMC9562990
ArticlePDF–2.1M
10.
Transarterial Chemoembolization (TACE) Combined With Sorafenib versus TACE in Patients With BCLC Stage C Hepatocellular Carcinoma – A Retrospective Study
Yashwant Patidar, Karamvir Chandel, Naveen K. Condati, Shyam V. Srinivasan, Amar Mukund, Shiv K. Sarin
J Clin Exp Hepatol. 2022 May-Jun; 12(3): 745–754. Published online 2021 Dec 21. doi: 10.1016/j.jceh.2021.12.009
PMCID:
PMC9168730
ArticlePDF–1.5M
11.
The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
Shun Liu, Kai-Cai Liu, Wei-Fu Lv, Dong Lu, Xian-Hai Zhu, Bo Jiang, Yu-Lin Tan, Guo-Xiang Wang
Front Med (Lausanne) 2021; 8: 774345. Published online 2021 Dec 3. doi: 10.3389/fmed.2021.774345
PMCID:
PMC8713136
ArticlePDF–659K
12.
Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice
Shaohua Li, Jie Mei, Qiaoxuan Wang, Feng Shi, Hongyan Liu, Ming Zhao, Lianghe Lu, Yihong Ling, Zhixing Guo, Yabing Guo, Xiaoming Chen, Ming Shi, Wan Yee Lau, Wei Wei, Rongping Guo
Hepatobiliary Surg Nutr. 2021 Oct; 10(5): 631–645. doi: 10.21037/hbsn.2020.03.14
PMCID:
PMC8527433
ArticlePDF–324K
13.
Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
Christine Koch, Markus Göller, Eckart Schott, Oliver Waidmann, Mark op den Winkel, Philipp Paprottka, Stephan Zangos, Thomas Vogl, Wolf Otto Bechstein, Stefan Zeuzem, Frank T. Kolligs, Jörg Trojan
Cancers (Basel) 2021 May; 13(9): 2121. Published online 2021 Apr 28. doi: 10.3390/cancers13092121
PMCID:
PMC8124282
ArticlePDF–1.7M
14.
Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy
Jenny Que, Chia-Hui Lin, Li-Ching Lin, Chung-Han Ho
Medicine (Baltimore) 2020 Aug 7; 99(32): e21561. Published online 2020 Aug 7. doi: 10.1097/MD.0000000000021561
PMCID:
PMC7593074
ArticlePDF–491K
15.
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
Kai-Cai Liu, Ying-Hong Hao, Wei-Fu Lv, Wei-Dong Jia, Chu-Shu Ji, Chun-Ze Zhou, De-Lei Cheng, Shao-Bao Xu, Zong-Gen Gao, Ming-Xue Su, Chang-Sheng Shi
Drug Des Devel Ther. 2020; 14: 3461–3468. Published online 2020 Aug 25. doi: 10.2147/DDDT.S248850
PMCID:
PMC7457560
ArticlePDF–2.4M
16.
Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy
Wen-Yen Huang, Chiao-Ling Tsai, Jenny Y. Que, Cheng-Hsiang Lo, Yu-Ju Lin, Yang-Hong Dai, Jen-Fu Yang, Po-Chien Shen, Mei-Hsuan Lee, Jason Chia-Hsien Cheng
Liver Cancer. 2020 Jun; 9(3): 326–337. Published online 2020 Mar 10. doi: 10.1159/000505693
PMCID:
PMC7325119
ArticlePDF–582K
17.
A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
Jie Mei, Shao‐Hua Li, Qiao‐Xuan Wang, Xiao‐Ping Zhong, Liang‐He Lu, Anna Kan, Wei Wei, Rong‐Ping Guo
Cancer Med. 2020 Jan; 9(1): 62–76. Published online 2019 Nov 8. doi: 10.1002/cam4.2671
PMCID:
PMC6943082
ArticlePDF–811K
18.
Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study
Shih-Chieh Chien, Chiung-Yu Chen, Pin-Nan Cheng, Yi-Shan Liu, Hsiu-Chi Cheng, Chiao-Hsiung Chuang, Ting-Tsung Chang, Hong-Chi Chiu, Yih-Jyh Lin, Yen-Cheng Chiu
Liver Cancer. 2019 May; 8(3): 186–202. Published online 2018 Jun 22. doi: 10.1159/000489790
PMCID:
PMC6547299
ArticlePDF–706K
19.
Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
Shiguang Chen, Wenchang Yu, Kongzhi Zhang, Weifu Liu
BMC Cancer. 2018; 18: 1131. Published online 2018 Nov 19. doi: 10.1186/s12885-018-5081-3
PMCID:
PMC6245751
ArticlePDF–802K
20.
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma
Francesca Romana Ponziani, Irene Spinelli, Emanuele Rinninella, Lucia Cerrito, Antonio Saviano, Alfonso Wolfango Avolio, Michele Basso, Luca Miele, Laura Riccardi, Maria Assunta Zocco, Brigida Eleonora Annicchiarico, Matteo Garcovich, Marco Biolato, Giuseppe Marrone, Anna Maria De Gaetano, Roberto Iezzi, Felice Giuliante, Fabio Maria Vecchio, Salvatore Agnes, Giovanni Addolorato, Massimo Siciliano, Gian Lodovico Rapaccini, Antonio Grieco, Antonio Gasbarrini, Maurizio Pompili
World J Hepatol. 2017 Dec 28; 9(36): 1322–1331. Published online 2017 Dec 28. doi: 10.4254/wjh.v9.i36.1322
PMCID:
PMC5756721
ArticlePDF–1.5M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center